Immutep Limited

IMMP | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.47

-$0.03 (-6.54%)

At close: May 20, 2026, 4:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-6.54%

(1D)

Rating

Updated: Apr 16, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $68.98M

1D Range

0.46 0.49

52W Range

0.29 3.53

Valuation (TTM)

PE -1.28

PB 1.05

EV/EBITDA -0.07

Valuation (NTM)

Forward PE N/A

Forward PEG N/A

Price Target $4.25

Cash Flow

FCF Yield -64.0%

SBC Adj. FCF Yield -65.2%

SBC Impact -1.9%

Margins

Gross Margin -522.6%

Operating Margin -1523.5%

FCF Margin -779.4%

Growth (CAGR)

Revenue 3Y | 5Y 209.3% | -7.6%

Dil EPS 3Y | 5Y -4.5% | -5.5%

FCF 3Y | 5Y -35.1% | -94.4%

Returns

ROA -57.0%

ROE -69.2%

ROIC -122.1%

Financial Health

Net Cash

A$99.13M ($66.15M)

Current Ratio 2.97

Interest Coverage -3,137.06

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and ...

Sector Healthcare

Industry Biotechnology

Employees 41

IPO Date Apr 18, 2012

Website www.immutep.com

Fiscal Year July - June

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Sep 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞